EU Approves Groundbreaking Twice-Yearly HIV Prevention Injection
The European Commission has approved lenacapavir, a twice-yearly HIV prevention injection, marking a major step in the fight against the virus across Europe.
The European Commission has approved lenacapavir, a twice-yearly HIV prevention injection, marking a major step in the fight against the virus across Europe.
